Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Trevi Therapeutics, Inc. (TRVI)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K10-K10-KS-1/A
Revenues  0.00.00.00.00.06.1
            Revenue growth      -100.0% 
Cost of goods sold  0.00.00.00.00.012.2
Gross profit  0.00.00.00.00.0-6.1
            Gross margin       -100.0%
Selling, general and administrative   [+]10.19.510.27.34.32.1
Research and development  19.823.022.319.314.1 
EBITDA   [+]  -32.4-26.6-18.4-8.2
            EBITDA margin       -135.1%
Depreciation and amortization    0.00.00.00.0
EBIT   [+]-29.9-32.5-32.5-26.6-18.4-8.2
            EBIT margin       -135.1%
Interest expense, net   [+]1.21.20.5-0.80.2 
Other income (expense), net   [+]1.9-0.30.2-0.2-2.1-4.6
Pre-tax income  -29.2-34.0-32.8-26.1-20.7-12.9
Income taxes  0.00.00.00.0-0.10.0
            Tax rate  0.1%0.1%0.1%0.1%0.6%0.2%
Net income  -29.2-33.9-32.8-26.8-25.6-12.9
            Net margin       -211.0%
   
Basic EPS   [+]($0.45)($1.49)($1.81)($2.28)($58.45)($29.80)
Diluted EPS   [+]($0.45)($1.49)($1.81)($2.28)($58.45)($29.80)
   
Shares outstanding (basic)   [+]64.522.818.111.70.40.4
Shares outstanding (diluted)   [+]64.522.818.111.70.40.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy